Loading...
Loading...
International Strategy & Investment Group (
ISI) reiterated a buy rating and $120 price target on biotech firm Biogen Idec
BIIB today. The price target implies only limited upside for the stock. The stock is up half a percent today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: Analyst ColorNewsPrice TargetReiterationIntraday UpdateMarketsAnalyst RatingsTrading Ideas
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
